CT-179 Targets Pediatric Brain Cancer

This is a U.S. news story, published by News | Emory University | Atlanta GA, that relates primarily to Day news.

U.S. news

For more U.S. news, you can click here:

more U.S. news

Day news

For more Day news, you can click here:

more Day news

biology news

For more biology news, you can click here:

more biology news

News | Emory University | Atlanta GA news

For more news from News | Emory University | Atlanta GA, you can click here:

more news from News | Emory University | Atlanta GA

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about

pediatric brain cancer

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest common childhood brain cancer news, brain cancers news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

childhood brain cancer

News | Emory University | Atlanta GA

•

Science

Childhood brain cancer research breakthrough could transform treatment, international study finds | Emory University | Atlanta GA

Summary

Nutrition label

90% Informative

Brain cancer is the second -leading cause of death in children in the developed world.

Emory University and QIMR Berghofer Medical Research Institute study shows a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.

The drug CT-179 was shown to target a specific subset of tumor cells responsible for recurrence and therapy resistance in pediatric brain cancer.

Day said the next step is to undertake clinical trials. “We've been working with our collaborators, particularly in the U.S. and Australia , and we're very hopeful that the culmination of all this work has paved the way for the first in-human clinical testing of CT-179 in patients with brain cancer,” Day says. The international collaboration included institutions in Canada , Australia , the U.S. , Korea and Sweden ..

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful